What is the recommended treatment for an acute gout flare?

Treatment of Acute Gout Flare

Corticosteroids are the preferred first-line therapy for acute gout flares due to comparable efficacy to NSAIDs with fewer adverse effects and lower cost. 1, 2

First-Line Anti-Inflammatory Options

You have three equally effective choices for treating an acute gout flare, but they differ in safety profile and cost:

Corticosteroids (Preferred)

• Prednisolone 35 mg orally daily for 5 days is the recommended regimen 1, 2
• Safer than NSAIDs with fewer adverse effects in short-term use 1, 2
• Lowest cost option among the three 1
• Contraindications: systemic fungal infections, known hypersensitivity 2
• Short-term risks include mood disturbances, elevated blood glucose, immunosuppression, and fluid retention 2

NSAIDs (Alternative)

• All NSAIDs demonstrate equivalent efficacy—indomethacin is NOT superior to other agents like naproxen or ibuprofen 1, 2
• Contraindications: renal disease, heart failure, cirrhosis 1, 2
• Adverse effects include dyspepsia and risk of gastrointestinal perforation, ulceration, and bleeding 1, 2

Colchicine (Alternative)

• Use low-dose regimen only: 1.2 mg followed by 0.6 mg one hour later 1, 2
• Low-dose is as effective as high-dose regimens but with markedly fewer gastrointestinal adverse effects (23% vs 77% diarrhea rate) 2
• Most expensive non-biologic option 2
• Contraindicated in patients with renal or hepatic impairment receiving potent CYP3A4 or P-glycoprotein inhibitors 1, 2
• Common adverse effects: diarrhea, nausea, vomiting, abdominal cramps 2

Critical Pitfall to Avoid

Never use high-dose colchicine regimens (e.g., 1.2 mg followed by 0.6 mg hourly for 6 hours)—they provide no additional therapeutic benefit and cause significantly more gastrointestinal toxicity 2

Initiating Urate-Lowering Therapy During Acute Flare

You can start urate-lowering therapy (ULT) during an acute flare—it does not prolong duration or increase severity of the flare 1, 2

• Starting ULT during a flare improves care efficiency and capitalizes on heightened patient motivation 2
• Always provide concomitant anti-inflammatory prophylaxis when initiating ULT 1, 2
• Prophylaxis options: colchicine, NSAIDs, or low-dose corticosteroids 1, 2
• Continue prophylaxis for 3-6 months rather than less than 3 months 1, 2
• Reassess regularly and extend prophylaxis if flares continue 1, 2

When to Start Long-Term ULT

Start ULT in patients with:

• Recurrent gout (≥2 episodes per year) 2
• Problematic gout features: tophi, chronic kidney disease, urolithiasis 2

Do NOT start long-term ULT after a single gout attack or when attacks are infrequent (<2 per year) 2

ULT Agent Selection

Allopurinol is the preferred first-line ULT agent for all patients, including those with moderate-to-severe chronic kidney disease (stage ≥3) 1

• Start with low dose (≤100 mg/day, lower in CKD stage ≥3) and titrate upward 1
• Maximum FDA-approved dose is 800 mg/day 1
• Low starting dose mitigates risk of allopurinol hypersensitivity syndrome 1
• Febuxostat (starting ≤40 mg/day) is an alternative, but recent evidence suggests cardiovascular concerns in certain populations 3